Izidore Lossos

1. Lossos IS, Reis IM, Rosenblatt JD, Alderuccio JP. Long-term outcomes of frontline ⁹⁰ Y-ibritumomab tiuxetan in marginal zone lymphoma. Leukemia and Lymphoma. 2020 Aug 5:1-5. Epub ahead of print.

 

2. Florindez JA, Alderuccio JP, Reis M, Lossos IS. Survival analysis in treated plasmablastic lymphoma patients: a population-based study. American Journal of Hematology. 2020 Aug 10. Epub ahead of print.

 

3. Florindez JA, Alderuccio JP, Lossos IS. Splenic marginal zone lymphoma: U.S. population-based survival analysis (1999-2016). Cancer. 2020 Aug 7. Epub ahead of print.

 

4. Husnain M, Kuker R, Reis IM, Iyer SG, Zhao W, Chapman JR, Vega F, Lossos IS, Alderuccio. Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: A single center analysis. Cancer Medicine. 2020 Jul 9;(14):5051-5064. Epub 2020 May 26.

 

5. Evens AM, Danilov AV, Jagadeesh D, Sperling AL, Kim SH, Vaca RA, Wei C, Rector D, Sundaram S, Reddy N, Lin Y, Farooq U, D’Angelo C, Bond D, Berg S, Churnetski MC, Godara A, Khan N, Choi YK, Sarraf Yazdy M, Rabinovich E, Varma G, Karmali R, Mian A, Savani M, Burkart M, Martin P, Ren A, Chauhan A, Diefenbach CS, Straker-Edwards A, Klein A, Blum K, Boughan K, Smith SE, Haverkos BM, Orellana-Noia VM, Kenkre V, Zayac AS, Ramdial J, Maliske S, Epperla N, Venugopal P, Feldman T, Smith SD, Stadnik A, David KA, Naik S, Lossos IS, Lunning M, Caimi PF, Kamdar M, Palmisiano N, Bachanova V, Portell CA, Phillips T, Olszewski AJ, Alderuccio JP. Burkitt Lymphoma in the Modern Era: Real World Outcomes and Prognostication Across 30 US Cancer Centers. Blood. 2020 Jul 14. Epub ahead of print.

 

6. Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S. Rodriguez Izquierdo A, Lossos IS, Reeder C, Sher T, Chen R, Schwarz S, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM. A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. Blood. 2020 Jul 30. Epub ahead of print.

 

7. Shoag JM, Barredo JC, Lossos IS, Pinheiro PS. Acute lymphoblastic leukemia mortality in Hispanic Americans. Leukemia and Lymphoma. 2020 Jun 22;1-8. Epub ahead of print.

 

8. Timmerman J, Herbaux C, Ribrag V, Zelenetz AD, Houot R, Neelapu SS, Logan T, Lossos IS, Urba W, Salles G, Ramchandren R, Jacobson C, Godwin J, Carpio C, Lathers D, Liu Y, Neely J, Suryawanshi S, Koguchi Y, Levy R. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.

American Journal of Hematology. 2020 May 95;(5):510-520. Epub 2020 Feb 29.

 

9. Liu F, Xu Y, Lu X, Hamard PJ, Karl DL, Man N, Mookhtiar AK, Martinez C, Lossos IS, Sun J, Nimer SD. PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2. Nucleic Acids Res. 2020 Apr 6;48(6):2956-2968.

 

10. Alderuccio JP, Isrow D, Reis IM, Iyer SG, Meshman JJ, Zhao W, Vega F, Chapman JR, Markoe AM, Lossos IS. Diagnostic bone marrow biopsy in patients with state I EMZL treated with radiation therapy: needed or not? Blood. 2020 Apr 9;135(15):1299-1302.

 

11. Chapman JR, Alvarez JP, White K, Sanchez S, Khanlari M, Algashaamy R, Cassidy D, Peng JH, Fan YS, Alencar A, Alderuccio JP, Lossos IS, Vega F. Unusual Variants of Follicular Lymphoma: Case-based Review. American Journal of Surgical Pathology. 2020 Mar;44(3):329-339 Epub 2019 Oct 29.

 

12. Guo F, Luo Y, Jiang X, Lu X, Roberti D, Lossos C, Kunkalla K, Magistri M, Rui L, Verdun R, Vega F, Moy VT, Lossos IS. Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL. Leukemia. 2020 Feb;34(2):553-566. Epub 2019 Sep 30.

 

13. Parvin Salma, Ramirez-Labrada Ariel, Aumann Shlomzion, Lu XiaoQing, Weich Natalia, Santiago Gabriel, Cortizas Elena M, Sharabi Eden, Zhang Yu, Sanchez-Garcia Isidro, Gentles Andrew J, Roberts Evan, Bilbao Cortes Daniel, Vega Francisco, Chapman Jennifer R, Verdun Ramiro E, Lossos Izidore S. LMO2 confers synthetic lethality to PARP inhibition in DLBCL. Cancer Cell. 2019 Sep 16;36(3):237-249.e6. Epub 2019 Aug 22.

 

14. Jiang Xiaoyu, Lu XiaoQing, Zhang Yu, Lacaria Leda, Schuchardt Bret J, Mikles David C, Magistri Marco, Garcia-Ramirez Idoia, Sanchez-Garcia Isidro, Farooq Amjad, Verdun Ramiro E, Abdulreda Midhat H, Moy Vincent T, Lossos Izidore S. Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling. Blood Advances. 2019 Aug 13;3(15):2286-2297.

 

15. Alderuccio JP, Zhao W, Desai A, Ramdial J, Gallastegui N, Kimble E, de la Fuente MI, Husnain M, Rosenblatt JD, Alencar AJ, Schatz JH, Moskowitz CH, Chapman JR, Vega F, Reis IM, Lossos IS. Short Survival and Frequent Transformation in Extranodal Marginal Zone Lymphoma with Multiple Mucosal Sites Presentation. American Journal of Hematology. 2019 May;94(5):585-596. Epub 2019 Mar 10.

 

16. de la Fuente MI, Alderuccio JP, Reis IM, Omuro A, Markoe A, Echegaray JJ, Davis JL, Harbour JW, Lossos IS. Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma. American Journal of Hematology. 2019 Apr;94(4):455-460. Epub 2019 Feb 4.

 

17. Hill BT, Nastoupil L, Winter AM, Becnel MR, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Fakhri B, Reddy P, Smith SD, Mukhija D, Jagadeesh D, Desai A, Pablo Alderuccio J, Lossos IS, Mehra P, Portell CA, Goldman ML, Calzada O, Cohen JB, Hussain MJ, Ghosh N, Caimi P, Tiutan T, Martin P, Kodali A, Evens AM, Kahl BS. Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma. British Journal of Haematology. 2019 184(4):524-535. Epub 2018 Dec 21

 

18. Mackrides N, Chapman J, Larson MC, Ramos JC, Toomey N, Lin P, Maurer MJ, Rafaelle M, Tan Y, Ikpatt O, Syrbu S, Ansell SM, Habermann TM, Link BK, Feldman AL, Lossos IS, Cerhan JR, Vega F. Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma. American Journal of Hematology. 2019 Feb 94(2):E62-E64. Epub 2018 Dec 5.

 

19. Husnain M, Mackrides N, Vega F, Paez-Escamilla M, Markoe AM, Harbour JW, Lossos IS. CD4+/CD8+ immunophenotype switching as a marker for intraocular and CNS involvement in mycosis fungoides. Leukemia and Lymphoma. 2019 May;60(5):1308-1311. Epub 2018 Nov 14.

 

20. Alderuccio JP, Mackrides N, Chapman JR, Vega F, Lossos IS. Rapid complete response to blinatumomab as a successful bridge to allogeneic stem cell transplantation in a case of refractory Richter syndrome. Leukemia and Lymphoma. 2019 Jan;60(1):230-233. Epub 2018 May 10.

 

21. Algashaamy K, Tan Y, Mackrides N, Alencar A, Peng JH, Rosenblatt J, Alderuccio JP, Lossos IS, Vega F, Chapman J. Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall. Case Reports Hematology. 2018; 2018:5761953.

 

22. Alderuccio JP, Zhao W, Desai A, Gallastegui N, Ramdial J, Kimble E, de la Fuente MI, Rosenblatt JD, Chapman JR, Vega F, Reis IM, Lossos IS. Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients with Marginal Zone Lymphoma From a Single Institution. Journal of Clinical Oncology. 2018; 36:3370-3380. Epub ahead of print 2018 Oct 12.

 

23. Mackrides N, Lossos IS, Vega F. Intracytoplasmic azurophilic inclusions in prolymphocytes. International Journal of Hematology. 2018 Dec 108(6):565. Epub 2018 Oct 9.

 

24. Qu C, Kunkalla K, Vaghefi A, Frederiksen JK, Liu Y, Chapman JR, Blonska M, Bernal-Mizrachi L, Alderuccio JP, Lossos IS, Landgraf R, Vega F. Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology. Cancer Letters. 2018 Nov 1 436:149-158. Epub 2018 Aug 27.

 

25. Lu X, Fernando T, Lossos C, Yusufova N, Liu F, Fontan L, Durant M, Geng H, Melnick J, Luo Y, Vega F, Moy V, Inghirami G, Nimer S, Melnick AM, Lossos IS. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival. Blood. 2018 Nov 8;132(19):2026-2039. Epub 2018 Aug 6.

 

26. Garcia-Ramirez I, Bhatia S, Rodriguez-Hernandez G, Gonzalez-Herrero I, Walter C, Gonzalez de Tea-Davila S, Parvin S, Haas O, Woessmann W, Stanulla M, Schrappe M, Dugas M, Natkunam Y, Orfao A,Dominguez V, Pintado B, Blanco O, Alonso-Lopez D, De Las Rivas j, Martin-Lorenzo A, Jimenez R, Garcia Criado FJ, Garcia Canador MB, Lossos IS, Vicente-Duenas C, Borkhardt A, Hauer J, Sanchez-Garcia I. LMO2 expression defines tumor cell identity during T-cell leukemogenesis. EMBO Journal. 2018 Jul 13;37(14). Epub 2018 Jun 7.

 

27. Alderuccio JP, Desai A, Yepes MM, Chapman JR, Vega F, Lossos IS. Frontline brentuximab vedotin in breast implant-associated anaplastic large-cell lymphoma. Clinical Case Reports. 2018 Feb 16;6(4):634-637. eCollection 2018 Apr.

 

28. Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA. MiR-181 family-specific behavior in different cancers: a meta-analysis view. Cancer Metastasis Review. 2018 Mar 37(1):17-32.

 

29. Alderuccio JP, Stefanovic A, Dammrich D, Chapman JR, Vega F, Selvaggi G, Tzakis A, Lossos IS. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy. Leukemia and Lymphoma. 2018 Sep 59(9): 2096-2104 Epub 2017 Dec18.

 

30. Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Pres OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK Gascoyne RD, Jaffe ES, Evens AM. Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Advances. 2017 Dec 11;1(26):2600-2609. eCollection 2017 Dec 12.

 

31. Kunder CA, Roncador G, Advani RH, Gualco G, Bacchi CE, Sabile JM, Lossos IS, Nie K, Tibshirani RJ, Green MR, Alizadeh AA, Natkunam Y. KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas. American Journal of Clinical Pathology. 2017 Nov 20;148(6):465-476.

 

32. Wang M, Schuster SJ, Phillips T, Lossos IS, Goy A, Rule S, Hamadani M, Ghosh N, Reeder CB, Barnett E, Bravo MC, Martin P. Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004). Journal of Hematology Oncology. 2017 Nov 2;10(1):171.

 

33. Guo X, Koff JL, Moffitt AB, Cinar M, Ramachandiran S, Chen Z, Switchenko JM, Mosunjac M, Neill SG, Mann KP, Bagirov M, Du Y, Natkunam Y, Khoury HJ, Rossi MR, Harris W, Flowers CR, Lossos IS, Boise LH, Dave SS, Kowalski J, Bernal-Mizrachi L. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. Oncogene. 2017 Jul 20;36(29):4224-4232. Epup 2017 Apr 3.

 

34. Wu SC, Chapman JR, Vega F, Abrahams N, Lossos IS, Alderuccio JP. Hepatosplenic T-cell lymphoma associated with membranoproliferative glomerulonephritis.  Leukemia and Lymphoma. 2017 Nov;58(11):2734-2737. Epub 2017 Mar 28.

 

35. Bhatt S, Parvin S, Zhang Y, Cho HM, Kunkalla K, Vega F, Timmerman JM, Shin SU, Rosenblatt JD, Lossos IS. Anti-CD20-Interleukin-21 fusokine targets malignant B-cells via direct apoptosis and NK-cell dependent cytotoxicity. Blood. 2017 Apr 20;129(16):2246-2256. Epub 2017 Jan 30.

 

36. McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Dave SS. The genetic basis of Hepatosplenic T cell lymphoma. Cancer Discovery. 2017 Apr;7(4):369-379. Epub 2017 Jan 25.

 

37. Abate F, da Silva Almeida AC, Zairis S, Robles J, Couronne L, Khiabanian H, Quinn SA, Kim M, Laginestra MA, Kim CS, Baghat G, Piris MA, Campo E, Lossos IS, Bernard O, Inghirami G, Pileri S, Bustelo X, Rabadan R, Ferrando A, Palomero T. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. PNAS/ Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):764-769. Epub 2017 Jan 6.

 

38. Mackrides N, Campuzano-Zuluaga G, Maque-Acosta Y, Moul A, Hijazi N, Ikpatt FO, Levy R, Verdun RE, Kunkalla K, Natkunam Y, Lossos IS, Vega F, Chapman J. Epstein-Barr virus-positive follicular lymphoma. Mod Pathol. 2017 Apr;30(4):519-529. Epub 2016 Dec 1.

 

39. Desai A, Joag MG, Lekakis L, Chapman JR, Vega F, Tibshirani R, Tse D, Markoe A, Lossos IS. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood.  2017 Jan 19;129(3):324-332. Epub 2016 Oct 27.
40. de la Fuente MI, Haggiagi A, Moul A, Young RJ, Sidani C, Markoe A, Vega F, DeAngelis LM, Lossos IS. Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leukemia and Lymphoma. 2017 Apr;58(4):882-888. Epub 2016 Sep 21.

 

41. Bhatt S, Sarosiek KA, Lossos IS. Interleukin 21 – its potential role in the therapy of B-cell lymphomas. Leukemia and Lymphoma. 2017 Jan 58(1):17-29. Epub 2016 Jul 13.

 

42. Alderuccio JP, Amarapurkar P, Chapman JR, Vega F, Lossos IS. Characteristics and outcomes of lymphoblastic lymphoma – the University of Miami experience. Leukemia and Lymphoma. 2017 Jan 58(1):195-198. Epub 2016 Jun 2.

 

43. Matthews JM, Bhatt S, Patricelli MP, Nomanbhoy TK, Jiang X, Natkunam Y, Gentles AJ, Martinez E, Zhu D, Chapman JR, Cortizas E, Shyam R, Chinichian S, Advani R, Tan L, Zhang J, Choi HG, Tibshirani R, Buhrlage SJ, Gratzinger D, Verdun R, Gray NS, Lossos IS. Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood. 2016 Jul 14;128(2):239-48. Epub 2016 May 5.

 

44. Healy JA, Nugent A, Rempel RE, Moffitt AB, Davis NS, Jiang X, Shingleton JR, Zhang J, Love C, Datta J, McKinney ME, Tzeng TJ, Wettschureck N, Offermanns S, Walzer KA, Chi JT, Rasheed SA, Casey PJ, Lossos IS, Dave SS. GNA13 loss in germinal center B cells leads to impaired apoptosis and GC B cell persistence and promotes lymphoma in vivo. Blood. 2016 Jun 2;127(22):2723-31. Epub 2016 Mar 17.

 

45. Kozloski GA, Jiang X, Bhatt Sm, Ruiz J, Vega F, Shaknovich R, Melnick A, Lossos IS. MiR-181a negatively regulates NF-?B signaling and affects activated B-cell like diffuse large B-cell lymphoma pathogenesis. Blood. 2016 Jun 9;127(23):2856-66. Epub 2016 Mar 3.

 

46. Argarwal NK, Kim CH, Kunkalla K, Konno H, Tjendra Y, Kwon D, Blonska M, Kozloski GA, Moy VT, Verdun RE, Barber GN, Lossos IS. Vega F. Active IKK? promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma. Blood. 2016 Feb 4;127(5):605-15. Epub 2015 Nov 24.

 

47. Ruiz-Cordero R, Lewis J, Blieden C, Campuzano-Zuluaga G, Hernandez J, Lossos IS, Ikpatt F, Chapman JR, Vega F. Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient. Human Pathology: Case Reports (2015) 2, 49-54.

 

48. Bhatt S, Matthews J, Parvin S, Sarosiek KA, Zhao D, Jiang X, Isik E, Letai A, Lossos IS. Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma. Blood. 2015 Sept 24;126(13):1555-64. Epub 2015 Jul 20.

 

49. Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort. American Journal of Hematology. 2015 Sep 90(9):778-83.

 

50. Chapman J, Gentles AJ, Sujoy V, Vega F, Dumur CI, Blevins TL, Bernal-Mizrachi L, Mosunjac M, Pimentel A, Zhu D, Lossos IS. Gene expression analysis of plasmablastic Lymphoma identifies down regulation of B cell receptor signaling and additional unique transcriptional programs. Leukemia. 2015 Nov;29(11):2270-3. Epub 2015 Apr 24.

 

51. Hosein PJ, Sandoval-Sus JD, Goodman D, Arteaga AG, Reis I, Hoffman J, Stefanovic A, Rosenblatt JD, Lossos IS. Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma. American Journal of Hematology. 2015 Jun 90(6):E111-6. Epub 2015 Apr 2.

 

52. Zhu D, Bhatt S, Lu X, Guo F, Veelken H, Hsu DK, Liu FT, Alvarez Cubela S, Kunkalla K, Vega F, Chapman-Fredricks JR, Lossos IS. Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas express self polyreactive B cell receptors. Leukemia. 2015 Jul 29(7):1587-99. Epub 2015 Feb 13.

 

53. Lu X, Sicard R, Jiang X, Stockus JN, McNamara G, Abdulreda M, Moy VT, Landgraf R, Lossos IS. HGAL localization to cell membrane regulates B-cell receptor signaling. Blood. 2015 Jan 22;125(4):649-57. Epub 2014 Nov 7.

 

54. Ramachandiran S, Adon A, Guo X, Wang Y, Wang H, Chen Z, Kowalski J, Sunay UR, Young AN, Brown T, Mar JC, Du Y, Fu H, Mann KP, Natkunam Y, Boise LH, Saavedra HI, Lossos IS, Bernal-Mizrachi L. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the non-canonical NF-?B pathway. International Journal of Cancer. 2015 May 15;136(10):2341-51. Epub 2014 Nov 11.

 

55. Lossos IS, Fabregas JC, Koru-Sengul T, Miao F, Goodman D, Serafini AN, Hosein PJ, Stefanovic A, Rosenblatt JD, Hoffman JE. Phase II Study of ⁹⁰Y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma. Leukemia and Lymphoma. 2015 Jun 56(6):1750-5. Epub 2014 Nov 20.
56. Mendez V, Martinez FJ, Soriano FB, Markoe AM, Lossos IS, Saigal K, Sussman DA. Novel use of endoscopic clips as fiducials for radiotherapy in small bowel lymphoma. ACG Case Reports Journal. 2014 July 1(4):184-6.

 

57. Green MR, Vicente-Duenas C, Romero-Camarero I, Long Liu C, Dai B, Gonzalez-Herrero I, Garcia-Ramirez I, Alonso-Escudero E, Iqbal J, Chan WC, Campos-Sanchez E, Orfao A, Pintado B, Flores T, Blanco O, Jimenez, R, Martinez-Climent JA, Criado FJ, Cenador MB, Zhao S, Natkunam Y, Lossos IS, Majeti R, Melnick A, Cobaleda C, Alizadeh AA, Sanchez-Garcia I. Transient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma. Nature Communications. 2014 Jun 2(5):3904
58. Chapman-Fredricks J, Sandoval-Sus J, Vega F, Lossos IS. Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and / or 13q14. Annals of Diagnostic Pathology. 2014 Aug 18(4):214-9. Epub 2014 Apr 13.

 

59. Evens AM, Smith MR, Lossos IS, Helenowski I, Millenson M, Winter JN, Rosen ST, Gordon LI. Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumor burden indolent non-Hodgkin lymphoma: a multicenter phase II study. British Journal of Haematology. 2014 Aug 166(4):514-20. Epub 2014 Apr 25.

 

60. Lossos C, Bayraktar S, Weinzierl E, Younes SF, Hosein PJ, Tibshirani RJ, Sutton Posthumus J, DeAngelis LM, Raizer J, Schiff D, Abrey L, Natkunam Y, Lossos IS. LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma. British Journal of Haematology. 2014 Jun 165(5):640-8. Epub 2014 Feb 26.

 

61. Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R, Evens AM, Islam N, Leonard JP, Martin P, Zelenetz AD, Lossos IS. A multicenter study of primary breast diffuse large B-cell lymphoma in the rituximab era. British Journal of Haematology. 2014 May 165(3):358-63. Epub 2014 Jan 27.

 

62. Palomero T, Couronné L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, Bernard OA, Rabadan R, Ferrando AA. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nature Genetics. 2014 Feb 46(2):166-70. Epub 2014 Jan 12.

 

63. Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos IS, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH. Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-Cell non-Hodgkin lymphomas. Journal of Clinical Oncology. 2014 Jan 1;32(1):44-50. Epub 2013 Sep 16.

 

64. Evens AM, Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R, Kroll-Dedrosiers A, Yarber JL, Sandoval J, Foyil K, Parker LM, Gordon LI, Blum KA, Flowers CR, Leornard JP, Habermann TM, Bartelett NL. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. Journal of Clinical Oncology. 2013 Nov 10;31(32):4132-9. Epub 2013 Sep 16.

 

65. Bhatt S, Ashlock BM, Natkunam Y, Sujoy V, Chapman JR, Ramos JC, Mesri EA, Lossos IS. CD30 targeting with brentuximab vedotin – a novel therapeutic approach to primary effusion lymphoma. Blood. 2013 Aug 15; 122(7):1233-42. Epub 2013 Jul 9.

 

66. Vose JM, Habermann TM, Czuczman MS, Zinzani PL, Reeder CB, Tuscano JM, Lossos IS, Li J, Pietronigro D, Witzig TE. Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation. British Journal of Haematology. 2013 Sep 162(5):639-47. Epub 2013 Jul 9.

 

67. Bertolo C, Roa S, Sagardoy A, Mena-Varas M, Robles EF, Martinez-Ferrandis JI, Sagaert X, Tousseyn T, Orta A, Lossos IS, Amar S, Natkunam Y, Briones J, Melnick A, Malumbres R, Martinez-Climent JA. LITAF, a BCL6 gene, regulates autophagy in mature B-cell lymphomas. British Journal of Haematology. 2013 Sep 162(5):621-30. Epub 2013 Jun 25.

 

68. Zhu D, Ikpatt OF, Dubovy SR, Lossos C, Natkunam Y, Chapman-Fredricks JR, Fan Y, Lossos IS. Molecular and Genomic Aberrations in Chlamydophila psittaci Negative Ocular Adnexal Marginal Zone Lymphomas. American Journal of Hematology. 2013 Sep 88(9):730-5. Epub 2013 Jul 23.

 

69. Tinoco G, Kanji R, Lossos IS, Hosein PJ. Acute Reversible Tetraplegia Induced by Hyperkalemia in a Patient with Paravertebral Mass due to Lymphoma. Journal of Clinical Case Reports. 2013 (3):4.

 

70. Matasar MJ, Czuczman MS, Rodriguez MA, Fennessy M,  Shea TC, Spitzer G, Lossos IS, Kharfan-Dabaja MA, Joyce R, Fayad L, Henkel K, Liao Q, Edvardsen K, Jewell RC, Fecteau D, Singh RP, Lisby S, Moskowitz CH. Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma. Blood. 2013 July 25;122(4):499-506. Epub 2013 May 21.
71. Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. Journal of Clinical Investigation. 2013 Jun 123(6):2616-28. Epub 2013 May 1.

 

72. Campuzano-Zuluaga G, Cioffi-Lavina M, Lossos IS, Chapman-Fredricks JR. Frequency and Extent of CD30 Expression in Diffuse Large B-Cell Lymphoma and its Relation to Clinical and Biologic Factors: A retrospective study of 167 cases. Leukemia Lymphoma. 2013 Nov 54(11):2405-11. Epub 2013 April 4.

 

73. Zhu D, Lossos C, Chapman-Fredricks JR, Lossos IS. Biased Immunoglobulin Light Chain Use in the Chlamydophila psittaci Negative Ocular Adnexal Marginal Zone Lymphomas. American Journal of Hematology. 2013 May 88(5):379-84. Epub 2013 March 28.

 

74. Romero-Camarero I, Jiang X, Natkunam Y, Lu X, Vicente-Duenas C, Gonzalez-Herrero I, Flores T, Garcia JL, McNamara G, Kunder C, Zhao S, Segura V, Fontan L, Martinez-Climent JA, Garcia-Criado FJ, Theis JD, Dogan A, Campos-Sanchez E, Green MR, Alizadeh AA, Cobaleda C, Sanchez-Garcia I, Lossos IS. Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nature Communications. 2013 Jan 8(4):1338.

 

75. Chapman-Fredricks J, Younes SF, Fan YS, Sandoval-Sus JD, Natkunam Y, Lossos IS. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract. Applied Immunohistochemistry & Molecular Morpholology. 2013 May 21(3):200-4.

 

76. Vincente-Duenas C, Romero-Camarero I, Gonzalez-Herrero I, Alonso-Escudero E, Abollo-Jimenez F, Jiang X, Gitierrez NC, Orfao A, Marin N, Villar LM, Fernandez Criado C, Pintado B, Flores T, Alonso-Lopez D, De Las Rivas J, Jimenez R, Garcia Criado FJ, Garcia Cenador MB, Lossos IS, Cobaleda C, Sanchez-Garcia I. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to hematopoietic progenitors. The EMBO Journal. 2012 Sep 12; 31(18):3704-17. Epub 2012 Aug 17.

 

77. Vicente-Duenas C, Fontan L, Gonzalez-Herrero I, Romero-Camarero I, Segura V, Aznar MA, Alonso-Escudero E, Campos-Sanchez E, Ruiz-Roca L, Barajas-Diego M, Sagardoy A, Martinez-Ferrandis JI, Abollo-Jimenez F, Bertolo C, Penuelas I, Garcia-Criado FJ, Garcia-Cenador MB, Tousseyn T, Agirre X, Prosper F, Garcia-Bragado F, McPhail ED, Lossos IS, Du MQ, Flores T, Hernandez-Rivas JM, Gonzalez M, Salar A, Bellosillo B, Conde E, Siebert R, Sagaert X, Cobaleda C, Sanchez-Garcia I, Martinez-Climant JA. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci USA. 2012 Jun 26; 109(26):10534-9. Epub 2012 Jun 11.

 

78. Warsch S, Hosein PJ, Morris MI, Teomete U, Benveniste R, Chapman JR, Lossos IS. Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab International Journal of Hematology. 2012 Aug 96(2):274-8. Epub 2012 Jun 9.

 

79. Cubedo E, Gentles AJ, Huang C, Natkunam Y, Bhatt S, Lu X, Jiang X, Romero-Camarero I, Freud A, Zhao S, Bacchi CE, Martínez-Climent JA, Sánchez-García I, Melnick A, Lossos IS. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. Blood. 2012 Jun 7; 119(23):5478-91. Epub 2012 Apr 19.

 

80. Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G, Matthews JM, Maurer MJ, Law ME, Bosler DS, Barrett M, Lossos IS, Witzig T, Fonseca R. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Modern Pathology. 2012 May 25(5):651-60. Epub 2012 Feb 3.

 

81. Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS. A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma. Leukemia Lymphoma. 2012 Jul 53(7):1299-305. Epub 2012 Jan 31.

 

82. Dagan LN, Jiang X, Bhatt S, Cubedo E, Rajewsky K, Lossos IS. miR-155 Regulates HGAL Expression and Increases Lymphoma Cell Motility. Blood. 2012 Jan 12;119(2):513-20. Epub 2011 Nov 16.

 

83. Hosein PJ, Craig MD,Tallman MS, Boccia RV, Hamilton BL, Lewis JJ, Lossos IS. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin’s and non-Hodgkin’s lymphoma. American Journal of Hematology. 2012 Jan 87(1):111-4. Epub 2011 Nov 12.

 

84. Cerhan JR, Natkunam Y, Morton LM, Maurer MJ, Asmann Y, Habermann TM, Vasef MA, Cozen W, Lynch CF, Allmer C, Slager SL, Lossos IS, Chanock SJ, Rothman N, Hartge P, Dogan A, Wang SS. LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. Leukemia Lymphoma. 2012 Jun 53(6):1105-12. Epub 2012 Jan 3.

 

85. Dagklis A, Ponzoni M, Govi S, Cangi MG, Pasini E, Charlotte F, Vino A, Doglioni C, Davi F, Lossos IS, Ntountas I, Papadaki T, Dolcetti R, Ferreri AJ, Stamatopoulos K, Ghia P. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Leukemia. 2012 Apr 26(4):814-21. Epub 2011 Oct 25.

 

86. Azambuja D, Natkunam Y, Biasoli I, Lossos IS, Anderson MW, Morais JC, Spector N. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin’s lymphoma. Ann Oncol.  2012 Mar 23(3):736-42. Epub 2011 May 20.

 

87. Zhu D, Lossos C, Chapman-Fredricks JR, Matthews JM, Ikpatt OF, Ruiz P, Lossos IS. Biased Use of the IGHV4 Family and Evidence for Antigen Selection in Chlamydophila psittaci-Negative Ocular Adnexal Extranodal Marginal Zone Lymphomas. PloS ONE. 2011 6(12):e29114. Epub 2011 Dec 27.

 

88. Hosein PJ, Pastorini VH, Paes FM, Eber D, Chapman JR, Serafini AN, Alizadeh AA, Lossos IS. Utility of positron emission tomography scans in mantle cell lymphoma. Am J Hematol. 2011 Oct 86(10):841-5. Epub 2011 Aug 22.

 

89. Morton LM, Cerhan JR, Hartge P, Vasef MA, Neppalli VT, Natkunam Y, Dogan A, Dave BJ, Jain S, Levy R, Lossos IS, Cozen W, Davis S, Schenk MJ, Maurer MJ, Lynch CF, Rothman N, Chatterjee N, Yu K, Staudt LM, Weisenburger DD, Wang SS. Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):245-52. Epub 2011 Jul 5.

 

90. Beltran E, Fresquet V, Martinez-Useros J, Richter-Larrea JA, Sagardoy A, Sesma I, Almada LL, Montes-Moreno S, Siebert R, Gesk S, Calasanz MJ, Malumbres R, Rieger M, Prosper F, Lossos IS, Piris MA, Fernandez-Zapico ME, Martinez-Climent JA. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma. Proc Natl Acad Sci USA. 2011 Jul 26;108(30):12461-6. Epub 2011 Jul 11.

 

91. Lossos C, Ferrell A, Duncan R, Lossos IS. Association Between Non Hodgkin’s Lymphomas and Renal Cell Carcinoma. Leukemia Lymphoma. 2011 Dec 52(12):2254-61. Epub 2011 Aug 24.

 

92. Cubedo E, Maurin M, Jiang X, Lossos IS, Wright KL. PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL. FEBS J. 2011 Sep 278(17):3065-75. Epub 2011 Aug 2.
93. Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood. 2011 Aug 4;118(5):1350-8. Epub 2011 Jun 13.

 

94. Alencar AJ, Malumbres R, Kozloski GA, Advani RH, Talreja N, Chinichian S, Birones J Natkunam Y, Sehn L, Gascoyne RD, Tibshirani R, Lossos IS. MicroRNAs are Independent Predictors of Outcome in Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP. Clinical Cancer Research. 2011 Jun 15;17(12):4125-35. Epub 2011 Apr 27.

 

95. Younes SF, Beck AH, Ohgami RS, Lossos IS, Levy R, Warnke RA, Natkunam Y. Immunoarchitectural Patterns in Follicular Lymphoma: the Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived from Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. Am J Clin Pathol. 2011 May 135(5):697-708.
96. Temmins C, Zhao S, Lossos IS, Natkunam Y. HGAL protein expression persists in disorders of germinal center dissolution: potential role of HGAL in the germinal center microenvironment. Applied Immunohistochemistry & Molecular Morphology. 2011 May 19(3):266-72.

 

97. Malumbres R, Fresquet V, Roman-Gomez J, Bobadilla M, Robles EF, Altobelli GG, Calasanz MJ, Smeland EB, Aznar MA, Agirre X, Martin-Palanco V, Prosper F, Lossos IS, Martinez-Climent JA. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome. Haematologica. 2011 Jul 96(7):980-6. Epub 2011 Apr 1.

 

98. Lu X, Kazmierczak K, Jiang X, Jones M, Watt J, Helfman DM, Moore JR, Szczesna-Cordary D, Lossos IS. Germinal center-specific protein human germinal center associated lymphoma directly interacts with both myosin and actin and increases the binding of myosin to actin. FEBS J. 2011 Jun 278(11):1922-31. Epub 2011 Apr 20.

 

99. Baecklund E, Backlin C, Mansouri M, Klareskog L, Askling J, Iliadou AN, Enblad G, Lossos IS, Natkunam Y, Rosenquist R. LMO2 protein expression predicts survival in rheumatoid arthritis patients with diffuse large B-cell Leuk Lymphoma. 2011 Jun 52(6):1146-9. Epub 2011 Feb 28.

 

100. Morgensztern D, Walker GR, Koniaris LG, Lossos IS. Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis. Leukemia Lymphoma. 2011 Feb 52(2):194-204.

 

101. Bayraktar S, Bayraktar UD, Stefanovic A. Lossos IS. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma MALT: Single institution experience in a large cohort of patients. Br J Haematol. 2011 Jan 152(1):72-80. Epub 2010 Nov 18.

 

102. Bayraktar S, Bayraktar UD, Ramos JC, Stefanovic A, Lossos IS. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. J Neurooncol. 2011 Jan 101(2):257-65.

 

103. Hansra D, Montague N, Stefanovic A, Akunyili I, Harzand A, Natkunam Y, De la Ossa M, Byrne GE, Lossos IS. Oral and extraoral plasmablastic lymphoma: Similarities and differences in clinicopathological characteristics. Am J Clin Pathol 2010 134(5):710-9.

 

104. Jiang X, Lu X, McNamara G, Liu X, Cubedo E, Sarosiek KA, Sánchez-García I, Helfman DM, Lossos IS. HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway. Blood. 2010 Dec 9;116(24):5217-27. Epub 2010 Sep 15.

 

105. Chao MP, Alizadeh AA, Tant C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres, R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 2010 Sep 3;142(5):699-713.

 

106. Younes SF, Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y. Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components. Am J Surg Pathol. 2010 Sep 34(9):1266-76

 

107. Durnick DK, Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, McPhail ED. Expression of LMO2 Is associated with t(14;18)/ IGH-BCL2 fusion but not BCL6 translocations in Diffuse Large B-Cell Lymphoma. Am J Clin Pathol. 2010 Aug 134(2):278-81.

 

108. Stefanovic A, Davis J, Murray T, Markoe A, Lossos IS. Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience. Br J Haematol. 2010 Oct 151(1):103-6. Epub 2010 Jul 12.

 

109. Sarosiek KA, Cavallin LE, Bhatt S, Toomey NL, Natkunam Y, Blasini W, Gentles AJ, Ramos JC, Mesri EA, Lossos, IS. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. PNAS. 2010 Jul 20;107(29):13069-74. Epub 2010 Jul 6.

 

110. Yoon SO, Zhang X, Freedman AS, Zahrieh D, Lossos IS, Li L, Choi YS. Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas. Am J Pathol. 2010 Jul 177(1):377-86. Epub 2010 Jun 21.

 

111. Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol. 2010 Oct 89(10):1003-9. Epub 2010 May 4.

 

112. Alizadeh AA, Bohen SP, Lossos C, Martinez-Climent JA, Ramos JC, Cubedo-Gil E, Harrington WJ Jr, Lossos IS. Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha. Leuk Lymphoma. 2010 Jul 51(7):1200-16.

 

113. Sarosiek KA, Malumbres R, Nechushtan H, Gentles AJ, Avisar E, Lossos IS. Novel IL-21 signaling pathway upregulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood. 2010 Jan 21;115(3):570-80. Epub 2009 Nov 20.

 

114. Anderson MW, Zhao S, Ai WZ, Tibshirani R, Levy R, Lossos IS, Natkunam Y. C-C chemokine receptor 1 expression in human hematolymphoid neoplasia. Am J Clin Pathol. 2010 Mar 133(3):473-83.

 

115. Lossos IS, Hosein PJ, Morgensztern D, Coleman F, Escalon MP, Byrne GE Jr, Rosenblatt JD, Walker GR. High rate and prolonged duration of complete remissions induced by R-MACLO-IVAM-T- a modification of the NCI 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma. Leuk Lymphoma. 2010 Mar 51(3):406-14.

 

116. Byrne MM, Lossos IS, Koniaris LG. What is the institutional financial impact of an MD-PhD Program without extramural funding? Teach Learn Med. 2010 Jan 22(1):56–9.

 

117. Gratzinger D, Advani R, Zhao S, Talreja N, Tibshirani R, Shyam R, Horning S, Sehn L, Farinha P, Briones J, Lossos IS, Gascoyne R, Natkunam Y. Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). Br J Haematol.  2010 Jan 148(2): 235-44. Epub 2009 Oct 11.

 

118. Alencar A, Pitcher D, Byrne GE Jr, Lossos IS. Primary Bone Lymphoma- University of Miami experience. Leuk Lymphoma 2010 Jan 51(1):39-49.

 

119. Metcalf RA, Zhao S, Anderson MW, Lu ZS, Galperin I, Marinelli RJ, Cherry AM, Lossos IS, Natkunam Y. Characterization of D-Cyclin proteins in hematolymphoid neoplasms: lack of specificity of Cyclins D2 and D3 expression in lymphoma subtypes. Modern Pathology 2010 Mar 23(3):420-33. Epub 2010 Jan 8.

 

120. Azambuja D, Lossos IS, Biasoli I, Morais JC, Britto L, Scheliga A, Pulcheri W, Natkunam Y, Spector N. Human Germinal center-Associated Lymphoma (HGAL) protein expression is associated with improved failure-free survival in Brazilian patients with Classical Hodgkin Lymphoma. Leuk Lymphoma. 2009 Nov 50(11):1830-6.

 

121. Sarosiek KA, Nechushtan H, Lu X, Rosenblatt JD, Lossos IS. Interleukin-4 distinctively modifies responses of Germinal Center-like and Activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy. Br J Haematol. 2009 Nov 147(3):308-18. Epub 2009 Aug 19.

 

122. Salama ME, Lossos IS, Warnke RA, Natkunam Y. Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: a study of 51 cases. Am J Surg Pathol. 2009 July 132(1):39-49.

 

123. Kalkanis D, Stefanovic A, Paes F, Escalon MP, Serafini A, Lossos IS. FDG-PET/CT detection of asymptomatic late pulmonary toxicity in non-Hodgkin lymphoma patients treated with rituximab-containing chemotherapy. Leuk Lymphoma. 2009 Jun 50(6):904-11.

 

124. Habermann TM, Lossos IS, Justice G, Vose JM, Wiernik PH, McBride K, Wride K, Ervin-Haynes A, Takeshita K, Pietronigro D, Zeldis JB, Tuscano JM. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br J Haematol. 2009 May 145(3):344-9. Epub 2009 Feb 24.

 

125. Alencar AJ, Bustinza E, Barker J, Byrne GE Jr, Lossos IS. Hematodermic tumor presenting with generalized skin involvement. J Clin Oncol. 2009 Jun 20;27(18):3059-61. Epub 2009 May 4.

 

126. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD, Tibshirani R, Lossos IS. Differentiation-Stage-Specific Expression of microRNAs in B-Lymphocytes and Diffuse Large B-Cell Lymphomas. Blood. 2009 Apr 16;113(16):3754-64. Epub 2008 Dec 1.

 

127. Han HS, Escalon MP, Hsiao B, Serafini A, Lossos IS. High Incidence of False Positive PET Scans in Patients with Aggressive Non-Hodgkins Lymphoma Treated with Rituximab-containing Regimens. Annals of Oncology. 2009 Feb 20(2):309-18. Epub 2008 Oct 7.
128. Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, Cubedo Gil E, Levy R, Lossos IS, Natkunam Y. The transcriptional factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Am J Clin Pathol. 2009 Feb 131(2):264-78.

 

129. Lu X, Malumbres R, Shields B, Natkunam Y, Jiang X, Tiganis T, Lossos IS. PTP1B is a Negative Regulator of Interleukin 4-induced STAT6 Signaling. Blood. 2008 Nov 15;112(10):4098-108. Epub 2008 Aug 20.

 

130. Malumbres R, Chen J, Tibshirani R, Johnson NA, Sehn LH, Natkunam Y, Briones J, Advani R, Connors JM, Byrne GE, Levy R, Gascoyne RD, Lossos IS. Paraffin-based 6-Gene Model Predicts Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP. Blood. 2008 Jun 15;111(12):5509-14. Epub 2008 Apr 29.

 

131. Wiernik PH, Lossos IS, Tuscano JM, Justice G, Vose JM, Cole CE, Lam W, McBride K, Wride K, Pietronigro D, Takeshita K, Ervin-Haynes A, Zeldis JB, Habermann TM. Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma. J Clin Oncol. 2008 Oct 20;26(30):4952-7. Epub 2008 Jul 7.

 

132. Stefanovic A, Morgensztern D, Fong T, Lossos IS. Pulmonary Marginal Zone Lymphoma: A Single Center Experience and Review of the SEER Database. Leuk Lymphoma. 2008 Jul 49(7):1311-20.

 

133. Pfeifer I, Elsby R, Fernandez M, Faria PA, Nussenzveig DR, Lossos IS, Fontoura BMA, Martin WD, Barber GN. NFAR-1 and -2 modulate translation and are required for efficient host defense. PNAS. 2008 Mar 18;105(11):4173-8. Epub 2008 Mar 12.

 

134. Matthews JM, Moreno LI, Dennis J, Byrne GE Jr, Ruiz P, Dubovy SR, Lossos IS. Ocular Adnexal Lymphoma: No Evidence for Bacterial DNA Associated with Lymphoma Pathogenesis. Br J Haematol. 2008 Jun 142(2):246-9. Epub 2008 May 19.

 

135. Baecklund E, Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundstrom C, Rosenquist R. Expression of the human germinal-center-associated lymphoma (HGAL) protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. Br J Haematol. 2008 Apr 141(1):69-72.

 

136. Xie X, Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED. Expression of HGAL in primary cutaneous large B cell lymphomas: Evidence for germinal center derivation of primary cutaneous follicular lymphoma.  Modern Pathology. 2008 Jun 21(6):653-9. Epub 2008 Feb 8.

 

137. Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, , Schiby G, Nagler A, Byrne GE Jr, Levy R, Gascoyne RD, Lossos IS. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rutiximab. J Clin Oncol. 2008 Jan 20;26(3):447–54. Epub 2007 Dec 17.

 

138. Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE Jr, Lossos IS, Natkunam Y.  Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest. 2008 88(1):38-47. Epub 2007 Nov 12.

 

139. Lu X, Chen J, Malumbres R, Cubedo Gil E, Helfman DM, Lossos IS. HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood. 2007 Dec 15;110(13):4268-77. Epub 2007 Sep 6.

 

140. Malumbres R, Davis J, Ruiz P, Lossos IS. Somatically mutated immunoglobulin IGVH @ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas. Br J Haematol. 2007 Sep 138(6):749-55.

 

141. Calfa CJ, Lossos IS, Ruiz P, Davis JL. Ocular involvement as the initial manifestation of a T-cell chronic lymphocytic leukemia. Am J Ophthalmol. 2007 Aug 144(2):326-9.

 

142. Lu X, Chen J, Sasmono RT, Hsi ED, Sarosiek KA, Tiganis T, Lossos IS. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell Lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol. 2007 27(6):2166-79. Epub 2007 Jan 8.

 

143. Natkunam Y, Vainer G, Chen J,  Zhao S,  Marinelli RJ, Hammer AS, Hamilton-Dutoit S, Pikarsky E, Amir G, Levy R, Yisraeli JK, Lossos IS. Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. Haematologica. 2007 92(2):176-83.

 

144. Chen J, Byrne GE Jr, Lossos IS. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues. Diagn Mol Pathol. 2007 Jun 16(2):61-72.

 

145. Ramos JC, Ruiz P Jr, Ratner L, Reis IM, Brites C, Pedroso C, Byrne GE Jr, Toomey NL, Andela V, Harhaj EW, Lossos IS, Harrington WJ Jr. IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood. 2007 Apr 1;109(7):3060–8.

 

146. Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton-Dutoit S, Lossos IS, Levy R. The Oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood. 2007 Feb 15;109(4):1636-42. Epub 2006 Oct 12.

 

147. Natkunam Y, Hsi ED, Aoun P, Zhao S, Elson P, Pohlman B, Naushad H, Bast M, Levy R, Lossos IS. Expression of the human germinal center- associated lymphoma (HGAL) protein identifies a subset of classical Hodgkin lymphoma of germinal center derivation and improved survival. Blood. 2007 1;109(1):298-305. Epub 2006 Sep 5.

 

148. Rosado MF, Byrne GE Jr, Ding F, Fields KA, Ruiz P, Dubovy SR, Walker GR, Markoe A, Lossos IS. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood. 2006 Jan 15;107(2):467-72. Epub 2005 Sep 15.

 

149. Abdullah S, Morgensztern D, Rosado MF, Lossos IS. Primary lymphoblastic B-cell lymphoma of the cranial dura mater: a case report and review of the literature. Leuk Lymphoma. 2005 Nov 46(11):1651-7.

 

150. Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA, Lossos IS. Distinct IL-4 induced gene expression, proliferation and intracellular signaling in germinal center B-cell like and activated B-cell like diffuse large cell lymphomas. Blood. 2005 Apr 1;105(7):2924-32. Epub 2004 Dec 9.

 

151. Natkunam Y, Lossos IS, Taidi B, Zhao S, Lu X, Ding F, Hammer AS, Marafioti T, Byrne Jr GE, Levy S, Warnke RA, Levy R.  Expression of the Human Germinal Center-Associated Lymphoma (HGAL) Protein, A New Marker of Germinal Center B Cell Derivation. Blood. 2005 May 15;105(10):3979-86. Epub 2005 Jan 27.

 

152. Chen D, Padiernos E, Ding F, Lossos IS, Lopez CD. Apoptosis stimulating protein p53-2(ASPP2/^53BP2L) is an E2F target gene. Cell Death Differ. 2005 Apr 12(4):358-68.

 

153. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, Levy R. Prediction of survival in diffuse large B-cell lymphoma based on the expression of six genes. N Eng J Med. 2004 Apr 29;350(18):1828-37.

 

154. Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell like and activated B-cell like diffuse large-cell lymphoma and is not correlated with intraclonal heterogeneity. Leukemia 2004 Nov 18(11):1775-9.

 

155. Morgensztern D, Rosado MF, Silva O, Santos ES, Abdullah SA, Goodman M, Hamilton-Nelson K, Rosenblatt JD, Lossos IS. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma. 2004 Dec 45(12):2459-64.

 

156. Rosado MF, Morgensztern D, Peleg M, Lossos IS. Primary diffuse large cell lymphoma of the mandible. Leuk Lymphoma. 2004 May 45(5):1049-53.

 

157. Morgensztern D, Rosado MF, Serafini AN, Lossos IS. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Leuk Lymphoma. 2004 Jun 45(6):1275-8.

 

158. Lossos IS, Akasaka T, Martinez-Climent JA, Siebert R, Levy R. The BCL6 gene in B-cell lymphomas with 3q27 translocations is expressed mainly from the rearranged allele irrespective of the partner gene. Leukemia. 2003 Jul 17(7):1390-7.
159. Lossos IS, Czerwinski DK, Wechser MA, Levy R. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia. 2003 Apr 17(4):789-95.

 

160. Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, Levy R. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood. 2003 Jan 15;101(2):433-40.

 

161. Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer MJS, Levy R, Pinkel D, Lossos IS. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood. 2003 Apr 15;101(8):3109-17. Epub 2002 Oct 24.

 

162. Akasaka T, Lossos IS, Levy R. BCL6 gene translocations in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood. 2003 Aug 15;102(4):1443-8. Epub 2003 May 8.

 

163. Do B, Lossos IS, Thorstenson Y, Oefner P, Levy R. Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma. 2003 Aug 44(8):1317-23.

 

164. Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of Follicular Lymphoma to Diffuse Large Cell Lymphoma:  alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8886-91. Epub 2002 Jun 19.

 

165. Lossos IS, Natkunam Y, Levy R, Lopez CD. Apoptosis Stimulating Protein of p53 (ASPP2) Expression Differs in Diffuse Large B-Cell and Follicular Center Lymphoma: Correlation with Clinical Outcome. Leuk Lymphoma. 2002 Dec 43(12):2309-17.

 

166. Lossos IS, Warnke R, Levy R. BCL-6 mRNA expression in higher-grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5’ regulatory region of the BCL-6 gene. Leukemia. 2002 Sep 16(9):1857-62.

 

167. Lossos IS, Or R, Ginzburg V, Christensen TG, Meshriki Y, Breuer R. Cyclosporin A up-modulates bleomycin – induced pulmonary injury in BALB/C mice. Respiration. 2002 6(4):344-9.

 

168. Huang JZ, Sanger WG, Greiner TC, Staudt LM, Weisenburger DD, Pickering DL, Lynch JC, Armitage JO, Warnke RA, Alizadeh AA, Lossos IS, Levy R, Chan WC. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood. 2002 Apr 1;99(7):2285-90.
169. Bokstein F, Lossos A, Lossos IS, Siegal T. CNS relapse of systemic non-Hodgkin's lymphoma: results of treatment based on high-dose methotrexate chemotherapy. Leuk Lymphoma. 2002 Mar 43(3):587-93.

 

170. Lossos IS, Thorstenson Y, Wayne TY, Oefner PJ, Levy R, Chu G. Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma. Leuk Lymphoma. 2002 May 43(5):1079-85.

 

171. Auffermann-Greitzinger S, Lossos IS, Vayntrub TA, Leong W, Grumet FG, Blume KG, Stockerl-Goldstein KE, Levy R, Shizuru JA. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood. 2002 Feb 15;99(4):1442-8.

 

172. Cantwell MJ, Wierda WG, Lossos IS, Levy R, Kipps TJ. T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154. Leukemia. 2001 Sep 15(9):1451-7.

 

173. Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R. The expression of single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2001 Aug 15;98(4):945-51.

 

174. Lossos IS, Jones CD, Zehnder JL, Levy R.  A polymorphism in the BCL-6 gene is associated with follicle center lymphoma. Leuk Lymphoma. 2001 Nov-Dec 42(6):1343-50.

 

175. Berkman N, Kremer S, Or R, Lossos IS, Christensen TG, Goldstein RH, Breuer R. Human recombinant interferon-a2a and interferon-aA/D have different effects on bleomycin-induced lung injury. Respiration. 2001 68(2):169-77.

 

176. Strahilevitz J, Lossos IS, Verstandig A, Sasson T, Kori Y, Gillis S. Vascular access via peripherally inserted central venous catheters (PICCs): Experience in 40 patients with acute myeloid leukemia at a single institution. Leuk Lymphoma. 2001 Jan 40(3-4):365-71.

 

177. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Jr., Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000 Feb 3;403(6769):503-11.

 

178. Lossos IS, Levy R. Mutation analysis of the 5' noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity. Blood. 2000 Feb 15;95(4):1400-5.

 

179. Lossos IS, Breuer R, Intrator O, Lossos A. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients. Cancer. 2000 Apr 1;88(7):1599-604.

 

180.  Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC, Levy R. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000 Mar 1;95(5):1797-803.
181. Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D, Staudt LM, Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10209-13.

 

182. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL- 6 gene. Blood. 2000 Jul 15;96(2):635-9.

 

183. Lossos IS, Izbicki G, Or R, Goldstein R, Breuer R. The effect of suramine on Bleomycin-induced lung injury. Life Sci. 2000 Oct 27;67(23):2873-81.

 

184. Sosna J, Lossos IS, Libson E. Hodgkin's lymphoma of the urinary bladder. Clin Radiol. 2000 May 55(5):405-6.

 

185. Lossos IS, Tibshirani R, Narasimhan B, Levy R. The inference of antigen selection on Ig genes. J Immunol. 2000 Nov 1;165(9):5122-6.

 

186. Raanani P, Shpilberg O, Gillis S, Avigdor A, Hardan I, Berkowicz M, Sofer O, Lossos I, Chetrit A, Ben-Yehuda D, Ben-Bassat I. Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine. Leuk Res. 1999 Aug 23(8):695-700.

 

187. Kremer S, Breuer R, Lossos IS, Berkman N, Christensen TG, Connor MW, Goldstein RH, Or R. Effect of immunomodulators on bleomycin-induced lung injury. Respiration. 1999 66(5):455-62.

 

188. Laxer U, Lossos IS, Gillis S, Or R, Christensen TG, Goldstein RH, Breuer R. The effect of enoxaparin on bleomycin-induced lung injury in mice. Exp Lung Res. 1999 Sep 25(6):531-41.

 

189. Lossos IS, Matzner Y. Anticardiolipin antibodies in myelodysplastic syndromes. Acta Haematol. 1999 101(3):161-2.

 

190. Lossos IS, Paltiel O, Polliack A. Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas. Leuk Lymphoma. 1999 Mar 33(1-2):155-60.

 

191. Lossos IS, Intrator O, Berkman N, Breuer R. Lactate dehydrogenase isoenzyme analysis for the diagnosis of pleural effusion in haemato-oncological patients. Respir Med. 1999 May 93(5):338-41.

 

192. Alizadeh A, Eisen M, Davis R, Ma C, Sabet H, Tran T, Powell J, Yang L, Marti G, Moore D, Hudson J, Chan W, Greiner T, Weisenburger D, Armitage J, Lossos IS, Levy R, Botstein D, Brown P, Staudt L. The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Proc. Symp. Quant. Biol. 1999 64:71-8.

 

193. Yossepowitch O, Lossos A, Lossos IS. Sudden hearing loss following acute hepatitis. Postgrad Med J. 1999 May 75(883):309-12.

 

194. Bogomolski-Yahalom V, Lossos IS, Okun E, Sherman Y, Lossos A, Polliack A. Intravascular lymphomatosis--an indolent or aggressive entity? Leuk Lymphoma. 1998 May 29(5-6):585-93.

 

195. Glazer M, Breuer R, Berkman N, Lossos IS, Kapelushnik J, Nagler A, Naparstek E, Kramer MR, Lafair J, Engelhard D, Or R. Use of fiberoptic bronchoscopy in bone marrow transplant recipients. Acta Haematol. 1998 99(1):22-6.

 

196. Lossos IS, Bogomolski-Yahalom V, Matzner Y. Anticardiolipin antibodies in acute myeloid leukemia: prevalence and clinical significance. Am J Hematol. 1998 Feb 57(2):139-43.

 

197. Lossos IS, Yossepowitch O, Kandel L, Yardeni D, Arber N. Septic arthritis of the          glenohumeral joint. A report of 11 cases and review of the literature. Medicine (Baltimore). 1998 May 77(3):177-87.

 

198. Lossos IS, Breuer R, Shriki M, Or R. Peribronchial lymphocyte activation in bleomycin-induced lung injury. Life Sci. 1998 63(13):1183-93.

 

199. Lossos IS, Bogomolski-Yahalome V, Yehuda O, Ben-Neriah S, Ben-Yehuda D, Leizerowitz R, Polliack A. A novel translocation (1;2)(p34;p21-22) in acute myelomonoblastic leukemia. Cancer Genet Cytogenet. 1998 Oct 106(1):78-9.

 

200. Sklair-Levy M, Libson Y, Lossos IS, Bugomolsky-Yahalom V. Splenic calcifications caused by Trichosporon beigelli infection: CT and ultrasound demonstration. Eur Radiol. 1998 8(6):922-4.

 

201. Ben Yehuda A, Lossos IS, Or R, Ben Chetrit E, Goldstein RH, Conner MW, Breuer R. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters. Pulm Pharmacol Ther. 1997 10:61-65.

 

202. Da'as N, Lossos IS, Yahalom V, Rund D, Wolf DG, Zelig O, Ben-Yehuda D. Candida abscess of the thyroid in a patient with acute lymphocytic leukemia. Eur J Med Res. 1997 Aug 28;2(8):365-6.

 

203. Golan G, Lebensart PD, Lossos IS. Ultrasound diagnosis and follow-up of testicular monocytic leukemia. J Clin Ultrasound. 1997 Oct 25(8):453-5.
204. Lossos IS, Okon E, Bogomolski-Yahalom V, Ron N, Polliack A. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a patient with isolated renotesticular involvement after cure of non-Hodgkin's lymphoma. Ann Hematol. 1997 Jan 74(1):41-4.

 

205. Yossepowitch O, Amir G, Safadi R, Lossos IS. Ischemic hepatitis associated with toxic epidermal necrolysis in a cirrhotic patient treated with cefuroxime. Eur J Med Res. 1997 Apr 21;2(4):182-4.
206. Lossos IS, Breuer R, Intrator O, Sonenblick M. Differential diagnosis of pleural effusion by lactate dehydrogenase isoenzyme analysis. Chest. 1997 Mar 111(3):648-51.

 

207. Lossos IS, Or R, Goldstein RH, Conner MW, Breuer R. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A. Exp Lung Res. 1996 May-Jun 22(3):337-49.

 

208. Lossos IS, Berger S, Gomori M, Leibovich G, Matzner Y. Hearing loss and leukocytosis. Postgrad Med J. 1996 Mar 72(845):183-5.

 

209. Lossos IS, Yossepowitch O, Amir G, Oren R. Naproxen associated leukocytoclastic vasculitis. Harefuah. 1996 May 1;130(9):600-1, 655.

 

210. Or R, Lossos IS, Hirschfeld E, Breuer R. Effect of interleukin-2 and interleukin-4 on lymphocytes from peribronchial lymphatic tissue. Exp Lung Res. 1996 Mar-Apr 22(2):245-53.

 

211. Breuer R, Lossos IS, Or R, Krymsky M, Dagan A, Yedgar S. Abatement of bleomycin-induced pulmonary injury by cell-impermeable inhibitor of phospholipase A2. Life Sci. 1995 57(16):PL237-40.

 

212. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, Naparstek E, Aker M, Nagler A, Moses AE, Shapiro M, et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation. 1995 Oct 15;60(7):672-8.

 

213. Yedgar S, Dan P, Dagan A, Ginsburg I, Lossos IS, Breuer R. Control of inflammatory processes by cell-impermeable inhibitors of phospholipase A2. Agents Actions Suppl. 1995 46:77-84.

 

214. Kaminski N, Lossos IS, Ben-Sira L, Laxer U, Jaffe R. Flank pain as a presentation of pulmonary embolism. Respir Med. 1995 Jan 89(1):65-6.

 

215. Lossos IS, Matzner Y. Hydroxyurea-induced fever: case report and review of the literature. Ann Pharmacother. 1995 Feb 29(2):132-3.

 

216. Schwaber M, Lossos IS, Goldberg Y, Jaffe R, Kaminski N. Right-sided endocarditis due to Staphylococcus aureus in a pregnant non-drug abuser with normal heart valves. Infect Dis Clin Pract. 1995 4:453-5.

 

217. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militianu A, Hassin D, Shai A, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore). 1994 Nov 73(6):299-305.

 

218. Lossos IS, Schwaber MJ, Levin T, Ackerman Z. Spontaneous peritonitis caused by Streptococcus bovis. J Clin Gastroenterol. 1994 Dec 19(4):346.

 

219.  Abolnik IZ, Lossos IS, Gillis D, Breuer R. Primary spontaneous pneumothorax in men. Am J Med Sci. 1993 May 305(5):297-303.

 

220. Mevorach D, Lossos IS, Oren R. Cefuroxime-induced fever. Ann Pharmacother. 1993 Jul-Aug 27(7-8):881-2.

 

221. Oren R, Lossos IS. Elevated creatine phosphokinase and creatine phosphokinase-MB in hyperventilation. Am J Med. 1993 Jan 94(1):113.

       

222. Leibowitz G, Amir G, Lossos IS, Eliakim R. Autoimmune polyglandular failure associated with malabsorption and gastric carcinoid tumour. J Intern Med. 1993 234:625-9.

 

223. Lossos IS, Oren R. Recurrent infective endocarditis. Postgrad Med J. 1993 Oct 69(816):816-8.

 

224. Lossos IS, Felsenstein I, Breuer R, Engelhard D. Food-borne outbreak of group A beta-hemolytic streptococcal pharyngitis. Arch Intern Med. 1992 Apr 152(4):853-5.

 

225. Abolnik IZ, Lossos IS, Zlotogora J, Brauer R. On the inheritance of primary spontaneous pneumothorax. Am J Med Genet. 1991 Aug 1;40(2):155-8.

 

226. Abolnik I, Lossos IS, Breuer R. Spontaneous pneumomediastinum. A report of 25 cases. Chest. 1991Jul 100(1):93-5.
227. Putterman C, Lossos IS. Author, verify your references! Or, the accuracy of references in Israeli medical journals. Isr J Med Sci. 1991 Feb 27(2):109-12.

 

228. Breuer R, Lossos IS, Lafair JS, Engelhard D. Utility of bronchoalveolar lavage in the assessment of diffuse pulmonary infiltrates in non-AIDS immunocompromised patients. Respir Med. 1990 Jul 84(4):313-6.

 

229. Gotterer N, Lossos I, Breuer R. Pancoast's syndrome caused by primary pulmonary hydatid cyst. Respir Med. 1990 Mar 84(2):169-70.

 

230. Lossos IS, Breuer R. Endobronchial metastasis from parotid gland tumour. J R Soc Med. 1990 Mar 83(3):191.
231. Lossos IS, Abolnik I, Breuer R. Pneumomediastinum: a complication of exposure to bromine. Br J Ind Med. 1990 Nov 47(11):784.

 

232. Lossos I, Israeli A, Zajicek G, Berry EM. Diagnosis deferred--the clinical        spectrum of diagnostic uncertainty. J Clin Epidemiol. 1989 42(7):649-57.

 

233. Lossos IS, Breuer R. Round pneumonia. Isr J Med Sci. 1989 Dec 25(12):713-14.

 

234. Lossos IS, Breuer R, Lafair JS. Endotracheal neurofibroma in a patient with von Recklinghausen's disease. Eur Respir J. 1988 May1(5):464-5.

 

20.  Other Works, Publications and Abstracts:

20a. Review Articles

 

1. Alderuccio JP, Lossos IS. Prognostic Factors and Risk of Transformation in Marginal Zone Lymphoma. 2020. Vol 4 (September 2020): Annals of Lymphoma.

 

2. de la Fuente MI, Alderuccio JP, Lossos IS. Central nervous system emergencies in haematological malignancies. British Journal of Haematology. 2020 Jun 189;(6):1028-1037. Epub 2019 Sep 4.

 

3. Alderuccio JP, Lossos IS. DA-EPOCH-R for Adult Burkitt’s Lymphoma: Pros and Cons. Journal of Oncology Practice. 2018 Nov 14(11):676-678.

 

4. Kozloski GA, Lossos IS. LymphomiRs: microRNAs with regulatory roles in lymphomas. Current Opinions in Hematology. 2015 Jul 22(4):362-8.

 

5. Hoffman J, Lossos IS. Commentary for Leukemia and Lymphoma: Lymphoma Associated Hemophagocytic Syndrome – It’s Going Viral. Leukemia Lymphoma. 2014 Sep 55(9):1964-5. Epub 2014 Jun 16.

 

6. Lossos IS. The DNA methylome: a novel biomarker. Blood. 2014 Mar 13;123(11):1627-8.

 

7. Deutsch YE, Lossos IS, Rosenblatt JD. Brentuximab vedotin for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: a review of clinical experience and future directions. International Journal of Hematology Oncology. 2013 2(6):455-65.

 

8. Ramos JC, Lossos IS. Newly Emerging Therapies Targeting Viral-related Lymphomas. Current Oncology Reports. 2011 Oct 13(5):416-26.

 

9. Lossos IS, Gascoyne RD. Transformation of follicular lymphoma, Best Practice & Research Clinical Haematology.  2011 June 24(2):147-63. Epub 2011 May 6.

 

10. Lossos IS. BLIMP1 against Lymphoma: The Verdict is Reached. Cancer Cell. 2010 Dec 14;18(6):537-9.

 

11. Malumbres R, Lossos IS. Expression of miRNAs in Lymphocytes: A Review. Methods Mol Biol. 2010 667:129-43.

 

12. Stefanovic A, Lossos IS. Primary testicular lymphoma: the site matters. Leuk Lymphoma. 2010 51(7):1159-60.

 

13. Hosein PJ, Lossos IS.  The evolving role of ¹⁸-F-FDG PET in patients with aggressive non-Hodgkin’s Lymphoma. European Journal of Clinical & Medical Oncology. 2010 2(1):131-8.

 

14. Stefanovic A, Lossos IS. Rare PTCLs: treatment lagging behind pathobiologic advances. Oncology. 2010 Jan 24(1):101-2.

 

15. Mann KK, Wallner B, Lossos IS, Miller WH Jr. Darinaparsin: a novel organic arsenical with promising anti-cancer Activity. Expert Opin Investig Drugs. 2009 Nov 18(11):1727-34.

 

16. Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009 Jul 16;114(3):501-10. Epub 2009 Apr 16.

 

17. Escalon MP, Lossos IS. Pharmacotherapy of large B-cell lymphoma. Expert Opin Pharmacother. 2008 Sep 9(13):2247-58.
18. Lossos IS. Diffuse Large B Cell Lymphoma: From Gene Expression Profiling to Prediction of Outcome. Biology of Blood and Marrow Transplantation. 2008 Jan 14(1 Suppl 1):108-11.

 

19. Alizadeh AA, Lossos IS. Double trouble in follicular lymphoma: a rare and unusual synergy of oncogenes in the germinal center. Leukemia and Lymphoma. 2008 Mar 49(3):377-80.

 

20. Lossos IS. The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression. Cancer Cell. 2007 12:189-91.

 

21. Lossos IS. IL-4 in lymphoma- does the target matter? Leuk Lymphoma. 2007 48:1261-3.

 

22. Morgensztern D, Martin MG, Lossos IS. Gene expression profiling in diffuse large B-cell lymphoma. Leuk Lymphoma. 2007 Apr 48(4):669-82.

 

23. Lossos IS. Closing the loop: p53-BCL6 feedback. Blood. 2006 107:1248-9.

 

24. Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol. 2006 Feb 20;24(6):995-1007. Epub 2006 Jan 17.
25. Lossos IS. Molecular pathogenesis of diffuse large B-cell lymphoma. J Clin Oncol. 2005 Sep 10;23(26):6351-7.

 

26. Morgensztern D, Lossos IS. Molecular prognostic factors in diffuse large B-cell lymphoma.  Curr Treat Options Oncol. 2005 Jul 6(4):269-77.

 

27. Lossos IS. Higher-grade transformation of follicular lymphoma – a continuous enigma. Leukemia. 2005 19:1331-33.

 

28. Lossos IS, Morgensztern D. Non-Hodgkin’s lymphoma in the microarray era. Clin Lymphoma. 2004 5:128-9.

 

29. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma:  phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biology. 2003 Jun 13(3):191-202.

 

30. Lossos IS, Levy R. Diffuse large B-cell lymphoma – insights gained from gene expression profiling. Int J Hematology. 2003 May 77(4):321-9.

 

31. Snider JV, Wechser MA, Lossos IS. Human disease characterization: real-time quantitative PCR analysis of gene expression. Drug Discovery Today. 2001 6:1062-7.
32. Kaminski N, Lossos IS, Breuer R. Nitric oxide in the respiratory system. Harefuah. 1995 Feb 1; 128(3):173-5.

 

33. Breuer R, Lossos IS, Berkman N, Or R. Pulmonary complications of bone marrow transplantation. Respir Med. 1993 Nov 87(8):571-9.

 

34. Lossos IS, Breuer R. Endobronchial metastases (editorial). Harefuah. 1989 116:339-40.

 

35. Lossos I, Breuer R. Pulmonary manifestations of rheumatoid arthritis. Harefuah. 1989 Oct 117(7-8):205-9.

 

36. Lossos I, Naparstek Y. Should asymptomatic ventricular premature beats be treated? Harefuah. 1987 113:180-2.

 

20b. Letters to the Editor

 

1. Weinstock DM, Dalla-Favera R, Gascoyne RD, Leonard JP, Levy R, Lossos IS, Melnick AM, Nowakowski GS, Press OW, Savage KJ, Shipp MA, Staudt LM. A roadmap for discovery and translation in lymphoma. Blood. 2015 Mar 26;125(13):2175-7.

 

2. Qing X, Sun N, French SW, Yue C, Montague N, Lossos IS. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics. Am J Clin Pathol. 2011 Jun 135(6):977-8.

 

3. Stefanovic A, Lossos IS. Variability in the prevalence of Chlamydophila psittaci infection in patients with OAML. Blood. 2009 114:3499-3500.

 

4. Alizadeh AA, Gentles AJ, Lossos IS, Levy R. Molecular outcome prediction in diffuse large B-cell lymphoma. N Eng J Med. 2009 360:2794-5.

 

5. Feilmeier MR, Lossos IS, Malumbres Rl, Schefler AC, Murray TG. Successful use of semi-nested PCR for the diagnosis of primary intraocular lymphoma [letter]. Leuk Lymphoma. 2008 Aug 49(8):1612-5.

 

6. Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J. Rituximab for treatment of chemo-immunotherapy naive marginal zone lymphoma [letter]. Leuk Lymphoma. 2007 Aug 48(8):1630-2.

 

7. Rosado MF, Morgensztern D, Sakher A, Ruiz P, Lossos IS. Chronic lymphocytic leukemia-associated nephritic syndrome caused by focal segmental glomerulosclerosis [letter]. Am J Hematol. 2004 Oct 77(2):205-6.

 

8. Lossos IS, Akasaka T, Levy R. Response: Multiple BCL6 translocations partners in individual cases of gastric lymphoma [letter]. Blood. 2003 102:1932.

 

9. Lossos IS, Jacobs Y, Cleary ML, Levy R. Correspondence re: Akasaka, H., et al., Molecular anatomy of BCL6 translocation revealed by long-distance polymerase chain reaction-based assay. Cancer Res., 60: 2335-2341, 2000 [letter]. Cancer Res. 2001 Oct 1;61(19):7363-4.
10. Lossos IS, Ben-Yehuda D. Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy [letter]. Ann Pharmacother. 1999 (33):253-54.

 

11. Lossos IS. Comment: drug-induced hiccups [letter; comment]. Ann Pharmacother. 1997 Oct 31(10):1264-5.

 

12. Halkin A, Lossos IS, Mevorach D. HMG-CoA reductase inhibitor-induced impotence [letter]. Ann Pharmacother. 1996 Feb 30(2):192.

 

13. Golan G, Lossos IS. Septicemia due to contaminated intravenous fluids: a point to remember [letter]. Mil Med. 1995 Oct 160(10):A12-3.

 

14. Golan G, Reichman JM, Lossos IS. Rectal examination: a potential hazard to physicians [letter]. J Clin Gastroenterol. 1995 Sep 21(2):173.

 

15. Lossos IS, Lossos A. Hazards of rapid administration of ceftriaxone [letter]. Ann Pharmacother. 1994 Jun 28(6):807-8.

 

16. Lossos IS, Matzner Y. Aplastic anemia associated with amiodarone therapy [letter]. Acta Haematol. 1992 87(4):213.

 

17. Lossos IS, Putterman C, Mainer Z. Massive haemothorax from central venous catheterization: a note of caution [letter] [published erratum appears in Arch Emerg Med 1993 Dec 10(4):390]. Arch Emerg Med. 1992 Sep 9(3):335-8.

 

18. Lossos IS, Mevorach D, Oren R. Thiethylperazine treatment of gastroparesis diabeticorum [letter]. Ann Pharmacother. 1992 Jul-Aug 26(7-8):1016.

 

19. Lossos IS, Breuer R. Endobronchial metastasis from Hurthle cell thyroid carcinoma [letter]. Chest. 1990 Mar 97(3):768.

 

20. Lossos IS. Sources of endobronchial metastases [letter; comment]. Chest. 1990 Nov 98(5):1308-9.

 

21. Lossos IS, Breuer R. A rare case of hiccups [letter]. N Engl J Med. 1988 Mar 17;318(11):711-2.